31
TITLE: Clastogenic factors as biomarkers of oxidative stress in HCV induced hepatocelular carcinoma: Comparison with chronic hepatitis C and liver metastases.  Full Text
AUTHORS: Serejo, F; Emerit, I; Filipe, P; Freitas, J; Velosa, J; Costa, A; Muora, MC;
PUBLISHED: 2002, SOURCE: 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD) in HEPATOLOGY, VOLUME: 36, ISSUE: 4
INDEXED IN: WOS
32
TITLE: Chronic hepatitis C and liver fibrosis, the significance of oxidative stress and implications of interferon treatment
AUTHORS: Serejo, FS; Filipe, P; Fernandes, A; Costa, A; Ramalho, F; Moura, MC;
PUBLISHED: 2001, SOURCE: JOURNAL OF HEPATOLOGY, VOLUME: 34
INDEXED IN: WOS
33
TITLE: HITS in internal carotid dissections
AUTHORS: Oliveira, V; Batista, P; Soares, F; Ferro, JM ;
PUBLISHED: 2001, SOURCE: CEREBROVASCULAR DISEASES, VOLUME: 11, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
34
TITLE: Apoptotic cell death does not parallel other indicators of liver damage in chronic hepatitis C patients  Full Text
AUTHORS: Rodrigues, CMP ; Brites, D ; Serejo, F; Costa, A; Ramalho, F ; de Moura, MC;
PUBLISHED: 2000, SOURCE: 34th Annual Meeting of the European-Association-for-the-Study-of-the-Liver-Diseases in JOURNAL OF VIRAL HEPATITIS, VOLUME: 7, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
35
TITLE: Interferon improves liver fibrosis in patients with chronic hepatitis C
AUTHORS: Serejo, F; Costa, A; Ramalho, F; Batista, A; Moura, MC;
PUBLISHED: 2000, SOURCE: JOURNAL OF HEPATOLOGY, VOLUME: 32
INDEXED IN: WOS CrossRef
36
TITLE: Sulindac associated to alpha interferon in a randomized controlled trial, improves chronic hepatitis C response. The significance of prostaglandin E2 (PGE2).  Full Text
AUTHORS: Serejo, F; Siqueira, MC; Gloria, H; Raimundo, M; Marinho, R; Velosa, J; Ramalho, F; Moura, MC;
PUBLISHED: 1998, SOURCE: HEPATOLOGY, VOLUME: 28, ISSUE: 4
INDEXED IN: WOS
37
TITLE: Adult Schonlein-Henoch purpura after enalapril  Full Text
AUTHORS: Goncalves, R; Pinto, HC; Serejo, F; Ramalho, F ;
PUBLISHED: 1998, SOURCE: JOURNAL OF INTERNAL MEDICINE, VOLUME: 244, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
38
TITLE: Bile duct lesion and Pi-glutathione-S-transferase (Pi-GST): Predictive markers of long term response to interferon treatment in chronic hepatitis C.  Full Text
AUTHORS: Serejo, F; Raimundo, M; Marinho, R; Gloria, H; Ramalho, F; Velos, J; Costa, A; Batista, A; Moura, MC;
PUBLISHED: 1998, SOURCE: GASTROENTEROLOGY, VOLUME: 114, ISSUE: 4
INDEXED IN: WOS
39
TITLE: Sustained response after interferon therapy in chronic hepatitis C (6 years of follow up): Significance of bile duct lesion and HCV genotypes.  Full Text
AUTHORS: Serejo, F; Raimundo, M; Marinho, R; Gloria, H; Velosa, J; Ramalho, F; Moura, MC; Costa, A; Batista, A;
PUBLISHED: 1997, SOURCE: HEPATOLOGY, VOLUME: 26, ISSUE: 4
INDEXED IN: WOS
40
TITLE: Adverse effects in hepatitis B and C treated with interferon. Any difference?  Full Text
AUTHORS: Marinho, R; Serejo, F; Raimundo, M; Gloria, H; Ramalho, F; Velosa, J; Moura, MC;
PUBLISHED: 1996, SOURCE: HEPATOLOGY, VOLUME: 24, ISSUE: 4
INDEXED IN: WOS
Page 4 of 5. Total results: 46.